Doctors Without Borders / Médecins Sans Frontières (MSF) invites you to attend the webinar series, “Overshadowed by COVID-19: Neglected Diseases in the Spotlight.”
The first in the series is “Hepatitis C: A Silent Killer.”
A majority of the estimated 58 million people infected by the hepatitis C virus live in low-and-middle income countries. Anyone can get infected with hepatitis C no matter where you live, yet millions don’t have access to treatment for this curable disease due to high prices, leaving many patients neglected. Why is this happening?
This webinar aims to discuss the following:
- Why are developing countries falling through the cracks when it comes to treatment for hepatitis C? What are the challenges for HCV patients?
- With the current COVID-19 pandemic, how has this exacerbated the lack of access to treatment and diagnostics for vulnerable populations around the world?
- 2030 is the target for eliminating HCV globally. What do governments and leaders need to do to ensure HCV patients have access to diagnostic and treatment?
WHEN: 29 July 2021, Thursday, 3:00 – 4:00 PM (Hong Kong) / 2:00 – 3:00 PM (Jakarta)
Than Meak, Project Coordinator, MSF Cambodia
Jean-Michel Piedagnel, Director of Regional Office, DNDi Southeast Asia
Dr. Chow Wan Cheng, Senior Consultant, Gastroenterology & Hepatology Department,
Singapore General Hospital
Moderator: Leena Menghaney, Regional Head for South Asia, MSF Access Campaign
For more information, visit: https://msf-seasia.org/hepatitisc